Oxfordshire, United Kingdom

Elisabeth Ann Bone

This inventor holds 1 USPTO granted patent. Top assignee: Convalife (Shanghai) Co. Limited. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elisabeth Ann Bone. Retrieved from https://idiyas.com/inventor/elisabeth-ann-bone-rbmchkjz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elisabeth Ann Bone: Innovator in Pharmaceutical Composition

Introduction

Elisabeth Ann Bone is a notable inventor based in Oxfordshire, GB. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on tricyclic heterocyclic compounds. Her expertise and dedication to research have led to the development of valuable pharmaceutical compositions.

Latest Patents

Elisabeth holds 1 patent for her invention titled "Compounds comprising tricyclic heterocyclic compounds." This patent relates to a pharmaceutical composition that includes a compound of formula I or a pharmaceutically acceptable salt thereof, along with various pharmaceutical excipients such as fillers, binders, disintegrants, glidants, and lubricants.

Career Highlights

Elisabeth is currently associated with Convalife (Shanghai) Co. Limited, where she continues to advance her research in pharmaceutical sciences. Her work has been instrumental in developing new therapeutic options that can improve patient outcomes.

Collaborations

Throughout her career, Elisabeth has collaborated with esteemed colleagues, including Stephen Joseph Shuttleworth and Franck Alexandre Silva. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.

Conclusion

Elisabeth Ann Bone's contributions to pharmaceutical innovation exemplify her commitment to advancing medical science. Her work on tricyclic heterocyclic compounds showcases her ability to create impactful solutions in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…